In our research, the activation of p38 MAPK/NF-κB signaling was observed in lung tissues of OVA-challenged mice, which was markedly repressed by Arctiin, suggesting that Arctiin may exert anti-asthma properties by inhibiting the p38 MAPK/NF-κB signaling pathway. This evidence concerns the gene NFKB1 and asthma.